The C.R. Bard Inc. (BCR) Position Boosted by Willingdon Wealth Management

The C.R. Bard Inc. (BCR) Position Boosted by Willingdon Wealth Management

Willingdon Wealth Management boosted its stake in C.R. Bard Inc. (NYSE:BCR) by 0.5% during the third quarter, Holdings Channel reports. The firm owned 8,651 shares of the company’s stock after buying an additional 46 shares during the period. Willingdon Wealth Management’s holdings in C.R. Bard were worth $1,940,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Whittier Trust Co. of Nevada Inc. boosted its position in shares of C.R. Bard by 43.7% in the second quarter. Whittier Trust Co. of Nevada Inc. now owns 454 shares of the company’s stock worth $107,000 after buying an additional 138 shares during the last quarter. Advisory Services Network LLC boosted its position in shares of C.R. Bard by 4.9% in the third quarter. Advisory Services Network LLC now owns 513 shares of the company’s stock worth $115,000 after buying an additional 24 shares during the last quarter. Mycio Wealth Partners LLC boosted its position in shares of C.R. Bard by 36.4% in the second quarter. Mycio Wealth Partners LLC now owns 599 shares of the company’s stock worth $141,000 after buying an additional 160 shares during the last quarter. Mizuho Asset Management Co. Ltd. boosted its position in shares of C.R. Bard by 75.0% in the second quarter. Mizuho Asset Management Co. Ltd. now owns 898 shares of the company’s stock worth $211,000 after buying an additional 385 shares during the last quarter. Finally, Shinko Asset Management Co. Ltd. boosted its position in shares of C.R. Bard by 60.1% in the third quarter. Shinko Asset Management Co. Ltd. now owns 975 shares of the company’s stock worth $219,000 after buying an additional 366 shares during the last quarter. 86.54% of the stock is owned by hedge funds and other institutional investors.

Shares of C.R. Bard Inc. (NYSE:BCR) traded down 1.13% during trading on Thursday, hitting $231.88. The company had a trading volume of 799,424 shares. The stock has a 50-day moving average of $222.34 and a 200 day moving average of $221.97. The stock has a market capitalization of $17.05 billion, a price-to-earnings ratio of 35.02 and a beta of 0.65. C.R. Bard Inc. has a 12-month low of $175.93 and a 12-month high of $239.43.

C.R. Bard (NYSE:BCR) last announced its quarterly earnings data on Tuesday, October 25th. The company reported $2.64 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.55 by $0.09. C.R. Bard had a net margin of 14.05% and a return on equity of 48.13%. The business had revenue of $941.90 million for the quarter, compared to analyst estimates of $931.66 million. During the same period last year, the business earned $2.28 EPS. The company’s revenue was up 8.8% on a year-over-year basis. On average, analysts predict that C.R. Bard Inc. will post $10.26 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, February 3rd. Investors of record on Monday, January 23rd will be paid a dividend of $0.26 per share. The ex-dividend date of this dividend is Thursday, January 19th. This represents a $1.04 annualized dividend and a yield of 0.45%. C.R. Bard’s dividend payout ratio is currently 15.48%.

A number of research analysts recently issued reports on the company. Raymond James Financial Inc. raised C.R. Bard from an “outperform” rating to a “strong-buy” rating and lifted their price target for the company from $250.00 to $265.00 in a report on Thursday, January 5th. Morgan Stanley raised C.R. Bard from an “equal weight” rating to an “overweight” rating and lifted their price target for the company from $240.00 to $260.00 in a report on Tuesday, January 3rd. Zacks Investment Research cut C.R. Bard from a “buy” rating to a “hold” rating in a report on Wednesday, December 21st. BMO Capital Markets raised C.R. Bard from a “market perform” rating to an “outperform” rating and set a $245.00 price target for the company in a report on Monday, December 12th. They noted that the move was a valuation call. Finally, Jefferies Group reaffirmed a “hold” rating and issued a $237.00 price target on shares of C.R. Bard in a report on Tuesday, September 27th. Nine investment analysts have rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. The stock has a consensus rating of “Buy” and an average price target of $236.87.

In other C.R. Bard news, VP John A. Deford sold 15,883 shares of the firm’s stock in a transaction on Monday, December 12th. The shares were sold at an average price of $218.03, for a total transaction of $3,462,970.49. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Christopher S. Holland sold 5,724 shares of the firm’s stock in a transaction on Friday, October 28th. The stock was sold at an average price of $211.12, for a total transaction of $1,208,450.88. The disclosure for this sale can be found here. Insiders have sold a total of 47,471 shares of company stock worth $10,423,231 over the last quarter. 0.97% of the stock is owned by company insiders.

About C.R. Bard

C. R. Bard, Inc (Bard) and its subsidiaries are engaged in designing, manufacturing, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. The Company sells its products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities.

Want to see what other hedge funds are holding BCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for C.R. Bard Inc. (NYSE:BCR).

Related posts

Leave a Comment